{"resourceType":"Bundle","type":"searchset","total":12,"link":[{"relation":"self","url":"http://tx.hl7.lt/fhir/ConceptMap?_page=1"},{"relation":"first","url":"http://tx.hl7.lt/fhir/ConceptMap?_page=1"},{"relation":"last","url":"http://tx.hl7.lt/fhir/ConceptMap?_page=2"},{"relation":"next","url":"http://tx.hl7.lt/fhir/ConceptMap?_page=2"}],"entry":[{"fullUrl":"ConceptMap/snomed_implicit_map_900000000000526001","resource":{"resourceType":"ConceptMap","id":"snomed_implicit_map_900000000000526001","text":{"status":"generated","div":"
This SNOMED CT Implicit Concept Map from http://snomed.info/sct?fhir_vs to http://snomed.info/sct?fhir_vs is generated using Reference Set 900000000000526001.
"},"url":"http://snomed.info/sct?fhir_cm=900000000000526001","name":"REPLACED BY"}},{"fullUrl":"ConceptMap/conceptmap-prostate-adpp-questionnaire-to-fhir-lt-prostate","resource":{"resourceType":"ConceptMap","id":"conceptmap-prostate-adpp-questionnaire-to-fhir-lt-prostate","language":"en","text":{"status":"generated","div":"

English

Generated Narrative: ConceptMap conceptmap-prostate-adpp-questionnaire-to-fhir-lt-prostate

Language: en

Mapping from (not specified) to (not specified)


Group 1 Mapping from ADPP primary assessment Questionnaire item (linkId)version: 0.0.1) to Prostate questionnaire → FHIR mapping target (illustrative)version: 0.0.1)

Source CodeRelationshipTarget CodeComment
assessment-datetime (Assessment date and time)is related toencounter-period (Encounter.period)Maps to EncounterLt.period (or effectiveDateTime on Observations created in this visit). Example: Encounter-encounter-prostate-diagnostic-example.
referral-reason (Reason for referral / programme entry)is related toservicerequest-reason (ServiceRequest.reasonCode)Populate ServiceRequestLt.reasonCode or Encounter.reasonCode. Example: ServiceRequest-servicerequest-pathology-prostate-order-example (LT Lab CI).
psa-recorded (PSA measured at this visit (flag))is related toobservation-psa-serum (Observation: PSA LOINC 2857-1)Boolean flag; actual value is ObservationLt with LOINC 2857-1. Example: Observation-observation-prostate-psa-example.
dre-result (Digital rectal examination (summary))is related toobservation-dre-finding (Observation: DRE finding)No dedicated DRE profile in LT Prostate; use ObservationLt (exam) with SNOMED or national codes. National spreadsheets add texture options (e.g. 276385001 Soft prostate) — extend answerOption and map to valueCodeableConcept.
family-hx-prostate (Family history: prostate cancer)is related tofamily-member-history-cancer (FamilyMemberHistory)Use FamilyMemberHistory with SNOMED situation codes (e.g. 414205003) as in national form notes. LT Base FamilyMemberHistory if profiled.
family-hx-breast (Family history: breast cancer)is related tofamily-member-history-cancer (FamilyMemberHistory (Base patterns) for oncologic family history)Same as family-hx-prostate; different relationship code.
family-hx-ovarian (Family history: ovarian cancer)is related tofamily-member-history-cancer (FamilyMemberHistory (Base patterns) for oncologic family history)Same pattern as other family history items.
family-hx-colon (Family history: colorectal cancer)is related tofamily-member-history-cancer (FamilyMemberHistory (Base patterns) for oncologic family history)Same pattern as other family history items.
height-cm (Height (cm))is related toobservation-body-height (Observation: body height (LT VitalSigns patterns))LT VitalSigns body height Observation. CI: Observation-observation-body-height-example.
weight-kg (Weight (kg))is related toobservation-body-weight (Observation: body weight (LT VitalSigns patterns))LT VitalSigns body weight Observation.
bmi-kg-m2 (BMI (kg/m²))is related toobservation-bmi (Observation: BMI (derived or LOINC))BMI Observation (LOINC 39156-5 or SNOMED 60621009). May be derived from height/weight.
first-psa-ngml (First PSA (ng/ml))is related toobservation-prior-psa (Observation: prior PSA value with effective time)ObservationLt PSA with effectiveDate aligned to first-psa-date.
first-psa-dateis related toobservation-prior-psa (Observation: prior PSA value with effective time)Observation.effective for the first PSA Observation.
second-psa-ngml (Second PSA (ng/ml))is related toobservation-prior-psa (Observation: prior PSA value with effective time)Second PSA Observation instance with effectiveDate from second-psa-date.
second-psa-dateis related toobservation-prior-psa (Observation: prior PSA value with effective time)Observation.effective for the second PSA Observation.
prior-mpmri (Prior mpMRI documented)is related toobservation-mpmri-history (Observation or Procedure: prior mpMRI / PI-RADS summary)Procedure or ImagingStudy + DiagnosticReport summary; or Observation with history context. Link to PI-RADS via prior-mpmri-pirads.
prior-mpmri-pirads (Prior mpMRI PI-RADS category)is related toobservation-mpmri-history (Observation or Procedure: prior mpMRI / PI-RADS summary)Align with PIRADSAssessmentLtProstate or past report narrative; not a substitute for full mpMRI bundle.
prior-prostatectomyis related toprocedure-prior-prostate-surgery (Procedure: prior prostate surgery)Procedure completed (ProcedureLt); national form also captures date — add Observation or Procedure.performedPeriod when available.
prior-prostate-radiation (Prior prostate radiotherapy)is related toprocedure-prior-prostate-radiation (Procedure: prior prostate radiotherapy)Procedure or History of radiation therapy (429479009) as situation Observation.
anticoagulant-useis related tomedicationstatement-anticoagulant (MedicationStatement: anticoagulant use)MedicationStatement or MedicationRequest; not profiled in this IG.
complaints-anamnesis (Complaints, anamnesis)is related toclinical-impression-or-note (Encounter / DocumentReference / ClinicalImpression for free-text programme notes)Free text: Encounter.reasonCode text, ClinicalImpression.summary, or DocumentReference.
specialist-additional-info (Additional information for specialist)is related toclinical-impression-or-note (Encounter / DocumentReference / ClinicalImpression for free-text programme notes)Same as complaints-anamnesis; often copied to ServiceRequest.note or referral DocumentReference.

Lithuanian

Generated Narrative: ConceptMap conceptmap-prostate-adpp-questionnaire-to-fhir-lt-prostate

Language: en

Mapping from (not specified) to (not specified)


Group 1 Mapping from ADPP primary assessment Questionnaire item (linkId)version: 0.0.1) to Prostate questionnaire → FHIR mapping target (illustrative)version: 0.0.1)

Source CodeRelationshipTarget CodeComment
assessment-datetime (Assessment date and time)is related toencounter-period (Encounter.period)Maps to EncounterLt.period (or effectiveDateTime on Observations created in this visit). Example: Encounter-encounter-prostate-diagnostic-example.
referral-reason (Reason for referral / programme entry)is related toservicerequest-reason (ServiceRequest.reasonCode)Populate ServiceRequestLt.reasonCode or Encounter.reasonCode. Example: ServiceRequest-servicerequest-pathology-prostate-order-example (LT Lab CI).
psa-recorded (PSA measured at this visit (flag))is related toobservation-psa-serum (Observation: PSA LOINC 2857-1)Boolean flag; actual value is ObservationLt with LOINC 2857-1. Example: Observation-observation-prostate-psa-example.
dre-result (Digital rectal examination (summary))is related toobservation-dre-finding (Observation: DRE finding)No dedicated DRE profile in LT Prostate; use ObservationLt (exam) with SNOMED or national codes. National spreadsheets add texture options (e.g. 276385001 Soft prostate) — extend answerOption and map to valueCodeableConcept.
family-hx-prostate (Family history: prostate cancer)is related tofamily-member-history-cancer (FamilyMemberHistory)Use FamilyMemberHistory with SNOMED situation codes (e.g. 414205003) as in national form notes. LT Base FamilyMemberHistory if profiled.
family-hx-breast (Family history: breast cancer)is related tofamily-member-history-cancer (FamilyMemberHistory (Base patterns) for oncologic family history)Same as family-hx-prostate; different relationship code.
family-hx-ovarian (Family history: ovarian cancer)is related tofamily-member-history-cancer (FamilyMemberHistory (Base patterns) for oncologic family history)Same pattern as other family history items.
family-hx-colon (Family history: colorectal cancer)is related tofamily-member-history-cancer (FamilyMemberHistory (Base patterns) for oncologic family history)Same pattern as other family history items.
height-cm (Height (cm))is related toobservation-body-height (Observation: body height (LT VitalSigns patterns))LT VitalSigns body height Observation. CI: Observation-observation-body-height-example.
weight-kg (Weight (kg))is related toobservation-body-weight (Observation: body weight (LT VitalSigns patterns))LT VitalSigns body weight Observation.
bmi-kg-m2 (BMI (kg/m²))is related toobservation-bmi (Observation: BMI (derived or LOINC))BMI Observation (LOINC 39156-5 or SNOMED 60621009). May be derived from height/weight.
first-psa-ngml (First PSA (ng/ml))is related toobservation-prior-psa (Observation: prior PSA value with effective time)ObservationLt PSA with effectiveDate aligned to first-psa-date.
first-psa-dateis related toobservation-prior-psa (Observation: prior PSA value with effective time)Observation.effective for the first PSA Observation.
second-psa-ngml (Second PSA (ng/ml))is related toobservation-prior-psa (Observation: prior PSA value with effective time)Second PSA Observation instance with effectiveDate from second-psa-date.
second-psa-dateis related toobservation-prior-psa (Observation: prior PSA value with effective time)Observation.effective for the second PSA Observation.
prior-mpmri (Prior mpMRI documented)is related toobservation-mpmri-history (Observation or Procedure: prior mpMRI / PI-RADS summary)Procedure or ImagingStudy + DiagnosticReport summary; or Observation with history context. Link to PI-RADS via prior-mpmri-pirads.
prior-mpmri-pirads (Prior mpMRI PI-RADS category)is related toobservation-mpmri-history (Observation or Procedure: prior mpMRI / PI-RADS summary)Align with PIRADSAssessmentLtProstate or past report narrative; not a substitute for full mpMRI bundle.
prior-prostatectomyis related toprocedure-prior-prostate-surgery (Procedure: prior prostate surgery)Procedure completed (ProcedureLt); national form also captures date — add Observation or Procedure.performedPeriod when available.
prior-prostate-radiation (Prior prostate radiotherapy)is related toprocedure-prior-prostate-radiation (Procedure: prior prostate radiotherapy)Procedure or History of radiation therapy (429479009) as situation Observation.
anticoagulant-useis related tomedicationstatement-anticoagulant (MedicationStatement: anticoagulant use)MedicationStatement or MedicationRequest; not profiled in this IG.
complaints-anamnesis (Complaints, anamnesis)is related toclinical-impression-or-note (Encounter / DocumentReference / ClinicalImpression for free-text programme notes)Free text: Encounter.reasonCode text, ClinicalImpression.summary, or DocumentReference.
specialist-additional-info (Additional information for specialist)is related toclinical-impression-or-note (Encounter / DocumentReference / ClinicalImpression for free-text programme notes)Same as complaints-anamnesis; often copied to ServiceRequest.note or referral DocumentReference.
"},"url":"https://hl7.lt/fhir/prostate/ConceptMap/prostate-adpp-questionnaire-to-fhir","version":"0.1.0","name":"ProstateAdppQuestionnaireToFhir","title":"ADPP Questionnaire items to FHIR mapping","status":"draft","experimental":true,"date":"2025-03-24","publisher":"Lithuanian Medical Library","contact":[{"name":"Lithuanian Medical Library","telecom":[{"system":"url","value":"https://medicinosnk.lt"},{"system":"email","value":"info@medicinosnk.lt"}]}],"description":"Maps ADPP primary assessment Questionnaire linkIds to LT Base / VitalSigns / Lifestyle / Lab patterns. Not a substitute for $extract or national transform logic.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"LT"}]}],"group":[{"source":"https://tx.hl7.lt/fhir/CodeSystem/prostate-adpp-questionnaire-item|0.0.1","target":"https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target|0.0.1","element":[{"code":"assessment-datetime","display":"Assessment date and time","target":[{"code":"encounter-period","display":"Encounter.period","relationship":"related-to","comment":"Maps to EncounterLt.period (or effectiveDateTime on Observations created in this visit). Example: Encounter-encounter-prostate-diagnostic-example."}]},{"code":"referral-reason","display":"Reason for referral / programme entry","target":[{"code":"servicerequest-reason","display":"ServiceRequest.reasonCode","relationship":"related-to","comment":"Populate ServiceRequestLt.reasonCode or Encounter.reasonCode. Example: ServiceRequest-servicerequest-pathology-prostate-order-example (LT Lab CI)."}]},{"code":"psa-recorded","display":"PSA measured at this visit (flag)","target":[{"code":"observation-psa-serum","display":"Observation: PSA LOINC 2857-1","relationship":"related-to","comment":"Boolean flag; actual value is ObservationLt with LOINC 2857-1. Example: Observation-observation-prostate-psa-example."}]},{"code":"dre-result","display":"Digital rectal examination (summary)","target":[{"code":"observation-dre-finding","display":"Observation: DRE finding","relationship":"related-to","comment":"No dedicated DRE profile in LT Prostate; use ObservationLt (exam) with SNOMED or national codes. National spreadsheets add texture options (e.g. 276385001 Soft prostate) — extend answerOption and map to valueCodeableConcept."}]},{"code":"family-hx-prostate","display":"Family history: prostate cancer","target":[{"code":"family-member-history-cancer","display":"FamilyMemberHistory","relationship":"related-to","comment":"Use FamilyMemberHistory with SNOMED situation codes (e.g. 414205003) as in national form notes. LT Base FamilyMemberHistory if profiled."}]},{"code":"family-hx-breast","display":"Family history: breast cancer","target":[{"code":"family-member-history-cancer","relationship":"related-to","comment":"Same as family-hx-prostate; different relationship code."}]},{"code":"family-hx-ovarian","display":"Family history: ovarian cancer","target":[{"code":"family-member-history-cancer","relationship":"related-to","comment":"Same pattern as other family history items."}]},{"code":"family-hx-colon","display":"Family history: colorectal cancer","target":[{"code":"family-member-history-cancer","relationship":"related-to","comment":"Same pattern as other family history items."}]},{"code":"height-cm","display":"Height (cm)","target":[{"code":"observation-body-height","relationship":"related-to","comment":"LT VitalSigns body height Observation. CI: Observation-observation-body-height-example."}]},{"code":"weight-kg","display":"Weight (kg)","target":[{"code":"observation-body-weight","relationship":"related-to","comment":"LT VitalSigns body weight Observation."}]},{"code":"bmi-kg-m2","display":"BMI (kg/m²)","target":[{"code":"observation-bmi","relationship":"related-to","comment":"BMI Observation (LOINC 39156-5 or SNOMED 60621009). May be derived from height/weight."}]},{"code":"first-psa-ngml","display":"First PSA (ng/ml)","target":[{"code":"observation-prior-psa","relationship":"related-to","comment":"ObservationLt PSA with effectiveDate aligned to first-psa-date."}]},{"code":"first-psa-date","display":"First PSA date","target":[{"code":"observation-prior-psa","relationship":"related-to","comment":"Observation.effective for the first PSA Observation."}]},{"code":"second-psa-ngml","display":"Second PSA (ng/ml)","target":[{"code":"observation-prior-psa","relationship":"related-to","comment":"Second PSA Observation instance with effectiveDate from second-psa-date."}]},{"code":"second-psa-date","display":"Second PSA date","target":[{"code":"observation-prior-psa","relationship":"related-to","comment":"Observation.effective for the second PSA Observation."}]},{"code":"prior-mpmri","display":"Prior mpMRI documented","target":[{"code":"observation-mpmri-history","relationship":"related-to","comment":"Procedure or ImagingStudy + DiagnosticReport summary; or Observation with history context. Link to PI-RADS via prior-mpmri-pirads."}]},{"code":"prior-mpmri-pirads","display":"Prior mpMRI PI-RADS category","target":[{"code":"observation-mpmri-history","relationship":"related-to","comment":"Align with PIRADSAssessmentLtProstate or past report narrative; not a substitute for full mpMRI bundle."}]},{"code":"prior-prostatectomy","display":"Prior prostatectomy","target":[{"code":"procedure-prior-prostate-surgery","relationship":"related-to","comment":"Procedure completed (ProcedureLt); national form also captures date — add Observation or Procedure.performedPeriod when available."}]},{"code":"prior-prostate-radiation","display":"Prior prostate radiotherapy","target":[{"code":"procedure-prior-prostate-radiation","relationship":"related-to","comment":"Procedure or History of radiation therapy (429479009) as situation Observation."}]},{"code":"anticoagulant-use","display":"Anticoagulant use","target":[{"code":"medicationstatement-anticoagulant","relationship":"related-to","comment":"MedicationStatement or MedicationRequest; not profiled in this IG."}]},{"code":"complaints-anamnesis","display":"Complaints, anamnesis","target":[{"code":"clinical-impression-or-note","relationship":"related-to","comment":"Free text: Encounter.reasonCode text, ClinicalImpression.summary, or DocumentReference."}]},{"code":"specialist-additional-info","display":"Additional information for specialist","target":[{"code":"clinical-impression-or-note","relationship":"related-to","comment":"Same as complaints-anamnesis; often copied to ServiceRequest.note or referral DocumentReference."}]}]}]}},{"fullUrl":"ConceptMap/snomed_implicit_map_6011000124106","resource":{"resourceType":"ConceptMap","id":"snomed_implicit_map_6011000124106","text":{"status":"generated","div":"
This SNOMED CT Implicit Concept Map from http://snomed.info/sct?fhir_vs to http://hl7.org/fhir/sid/icd-10-cm?fhir_vs is generated using Reference Set 6011000124106.
"},"url":"http://snomed.info/sct?fhir_cm=6011000124106","name":"SNOMED CT to ICD-10-CM complex map"}},{"fullUrl":"ConceptMap/snomed_implicit_map_447562003","resource":{"resourceType":"ConceptMap","id":"snomed_implicit_map_447562003","text":{"status":"generated","div":"
This SNOMED CT Implicit Concept Map from http://snomed.info/sct?fhir_vs to http://hl7.org/fhir/sid/icd-10?fhir_vs is generated using Reference Set 447562003.
"},"url":"http://snomed.info/sct?fhir_cm=447562003","name":"SNOMED CT to ICD-10 extended map"}},{"fullUrl":"ConceptMap/conceptmap-cvd-risk-assessment-questionnaire","resource":{"resourceType":"ConceptMap","id":"conceptmap-cvd-risk-assessment-questionnaire","language":"en","text":{"status":"generated","div":"

English

Generated Narrative: ConceptMap conceptmap-cvd-risk-assessment-questionnaire

Language: en

Mapping from (not specified) to (not specified)


Group 1 Mapping from CVD risk assessment questionnaire item (linkId)version: 0.1.0) to CVD questionnaire mapping target (profiles)version: 0.1.0)

Source CodeRelationshipTarget CodeComment
grp-context (Context group)is related toobservation-lt (ObservationLt (LT Base))Section header. Registrar, institution, and workstation context typically use LT Base Patient, Practitioner, Organization, and PractitionerRole (not itemised in the illustrative Questionnaire). LT Base IG: https://hl7.lt/fhir/base/ImplementationGuide/lt.hl7.fhir.base
evaluation-datetime (Evaluation date and time)is related tocvd-risk-assessment-lt-cvdAligns with Observation.effectiveDateTime on CVDRiskAssessmentLtCvd. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/cvd-risk-assessment-lt-cvd. Example: observation-cvd-risk-assessment-example. CVD IG: https://hl7.lt/fhir/cvd/ImplementationGuide/lt.hl7.fhir.cvd
grp-chronic (Accompanying chronic diseases)is related tocvd-chronic-condition-lt-cvdSection header for accompanying chronic diseases; child items use CvdChronicConditionLtCvd.
chronic-condition-summary (Chronic conditions summary)is related tocvd-chronic-condition-lt-cvdMap programme text to Condition with CvdChronicConditionLtCvd (ICD-10). StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/cvd-chronic-condition-lt-cvd. Example: condition-cvd-heart-failure-example.
grp-risk-factors (Risk factors)is related torisk-factor-status-lt-cvdSection header for programme risk-factor items (RiskFactorStatusLtCvd).
risk-factor-hypertension (Arterial hypertension)is related torisk-factor-status-lt-cvdRiskFactorStatusLtCvd. Example: observation-hypertension-negligible-example. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/risk-factor-status-lt-cvd
risk-factor-dyslipidemia (Dyslipidemia)is related torisk-factor-status-lt-cvdRiskFactorStatusLtCvd. Example: observation-dyslipidemia-treated-example.
risk-factor-diabetes (Diabetes)is related torisk-factor-status-lt-cvdRiskFactorStatusLtCvd. Example: observation-diabetes-untreated-example.
risk-factor-smoking (Smoking)is related totobacco-use-lt-lifestyleTobaccoUseLtLifestyle (LT Lifestyle). StructureDefinition: https://hl7.lt/fhir/lifestyle/StructureDefinition/tobacco-use-lt-lifestyle. CI example: https://build.fhir.org/ig/HL7LT/ig-lt-lifestyle/Observation-observation-tobacco-use-current-smoker-example.html
grp-objective (Objective condition and investigations)is related tobody-height (BodyHeight (Vital Signs))Section header for anthropometrics and blood pressure (LT Vital Signs IG). See child items for BodyHeight, BodyWeight, WaistCircumference, BloodPressurePanel. Vital Signs IG: https://hl7.lt/fhir/vitalsigns/ImplementationGuide/lt.hl7.fhir.vitalsigns
height-cm (Height (cm))is related tobody-height (BodyHeight (Vital Signs))BodyHeight. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/body-height. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-body-height-example.html
weight-kg (Weight (kg))is related tobody-weight (BodyWeight (Vital Signs))BodyWeight. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/body-weight. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-body-weight-example.html
waist-cm (Waist circumference (cm))is related towaist-circumference (WaistCircumference (Vital Signs))WaistCircumference. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/waist-circumference. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-waist-circumference-example.html
bp-systolic (Systolic blood pressure (mmHg))is related toblood-pressure-panel (BloodPressurePanel (Vital Signs))BloodPressurePanel (systolic component). StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/blood-pressure-panel. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-blood-pressure-example.html
bp-diastolic (Diastolic blood pressure (mmHg))is related toblood-pressure-panel (BloodPressurePanel (Vital Signs))BloodPressurePanel (diastolic component); same Observation as systolic.
grp-lipidogram (Lipidogram)is related tolipidogram-lab-ltLipid panel section. Composite lab example: observation-lipidogram-example. Lab IG: https://hl7.lt/fhir/lab/ImplementationGuide/lt.hl7.fhir.lab. CI: https://build.fhir.org/ig/HL7LT/ig-lt-lab/Observation-observation-lipidogram-example.html
lipid-tc (Total cholesterol (mmol/l))is related tototal-cholesterol-lab-ltTotalCholesterolLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/total-cholesterol-lab-lt. Same CI lipidogram example as other lipid items.
lipid-hdl (HDL cholesterol (mmol/l))is related tocholesterol-hdl-lab-ltCholesterolHdlLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/cholesterol-hdl-lab-lt.
lipid-ldl (LDL cholesterol (mmol/l))is related tocholesterol-ldl-lab-ltCholesterolLdlLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/cholesterol-ldl-lab-lt.
lipid-tg (Triglycerides (mmol/l))is related totriglycerides-lab-ltTriglyceridesLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/triglycerides-lab-lt.
grp-risk-estimate (Risk estimate and group)is related tocvd-risk-assessment-lt-cvdSection for SCORE2 and programme risk group (CVD IG).
score2-percent (SCORE2 cardiovascular risk (%))is related tocvd-risk-assessment-lt-cvdSCORE2 as valueQuantity (%). CVDRiskAssessmentLtCvd. Example: observation-cvd-risk-assessment-example.
risk-group-cvd (Risk group for heart and vascular diseases)is related torisk-group-observation-lt-cvdRiskGroupObservationLtCvd. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/risk-group-observation-lt-cvd. Example: observation-risk-group-high-example.
grp-migration-md-parity (Migration mapping.md — extended parity)is related toobservation-lt (ObservationLt (LT Base))Section for input/fsh/migration/mapping.md parity: concepts listed as missing in sibling IGs or as extended investigations. Rows 3–12,16–17 (BP, vitals, lipids, smoking) are covered by sibling items above.
mig-encounter (Encounter (visit context))is related toencounter-lt (EncounterLt (LT Base))mapping.md row 1 — Encounter. StructureDefinition: https://hl7.lt/fhir/base/StructureDefinition/encounter-lt. Base example: encounter-psychiatric-example.
mig-practitioner-role (PractitionerRole (workplace))is related topractitioner-role-lt (PractitionerRoleLt (LT Base))mapping.md row 2 — PractitionerRole. StructureDefinition: https://hl7.lt/fhir/base/StructureDefinition/practitioner-role-lt. Example: practitioner-role-doctor-vilnius-hospital-example.
mig-heart-rate (Heart rate (bpm))is related toheart-rate (HeartRate (Vital Signs))mapping.md row 4 — Heart rate. Vital Signs heart-rate profile. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/
mig-bmi (BMI (kg/m²))is related tobmi (BMI (Vital Signs))mapping.md row 7 — BMI. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/bmi
mig-glucose-fasting (Fasting glucose (mmol/l))is related toglucose-venous-lab-ltmapping.md row 13 — Fasting glucose. Lab: glucose-venous-lab-lt.
mig-hba1c (HbA1c (%))is related tohba1c-lab-ltmapping.md row 14 — HbA1c. Lab: hba1c-lab-lt.
mig-creatinine (Creatinine)is related tocreatinine-test-lab-ltmapping.md row 15 — Creatinine. Lab: creatinine-test-lab-lt.
mig-egfr (eGFR)is related toegfr-lab-ltmapping.md row 15 — eGFR. Lab: egfr-lab-lt.
mig-alcohol (Alcohol consumption)is related toalcohol-consumption-lt-lifestylemapping.md row 18 — Alcohol. Lifestyle: alcohol-consumption-lt-lifestyle.
mig-physical-activity (Physical activity (summary))is related tophysical-activity-lt-lifestylemapping.md row 19 — Physical activity. Lifestyle: physical-activity-lt-lifestyle.
mig-nutrition (Dietary habits / nutrition)is related tonutrition-lt-lifestylemapping.md row 20 — Dietary habits. Lifestyle: nutrition-lt-lifestyle.
mig-family-cvd (Family history of CVD)is related tofamily-history-cvd-lt-lifestylemapping.md row 21 — Family CVD history. Lifestyle: family-history-cvd-lt-lifestyle.
mig-referral (Referral)is related toservice-request-lt (ServiceRequestLt (LT Base))mapping.md row 22 — Referral. Base ServiceRequestLt (no example in IGs; profile only).
mig-follow-up-appointment (Follow-up visit / appointment)is related toappointment-lt (AppointmentLt (LT Base))mapping.md row 23 — Follow-up visit. Base AppointmentLt (no example in IGs; profile only).
mig-achievement-round (Achievement evaluation (narrative))is related toobservation-lt (ObservationLt (LT Base))mapping.md row 24 — Achievement evaluation at second timepoint; use prevention Questionnaire achievement group or repeat vitals/labs/lifestyle Observations.
mig-chronic-additional (Additional chronic conditions)is related tocvd-chronic-condition-lt-cvdmapping.md row 25 — Additional chronic conditions (depression, COPD, AF, …). CvdChronicConditionLtCvd.
grp-ig-example-parity (IG example parity (migration already-covered))is related toobservation-lt (ObservationLt (LT Base))Section for migration already-covered table: context notes and EKG/medication/diabetes duration.
ac-patient-context (Patient (context note))is related topatient-lt (PatientLt (LT Base))Maps to PatientLt; QuestionnaireResponse.subject typically carries the Patient. Example: patient-male-example.
ac-practitioner-context (Practitioner (context note))is related topractitioner-lt (PractitionerLt (LT Base))Maps to PractitionerLt; QuestionnaireResponse.author. Example: practitioner-example.
ac-organization-context (Organization (context note))is related toorganization-lt (OrganizationLt (LT Base))Maps to OrganizationLt; use context in CarePlan/Encounter. Example: organization-example.
ac-ekg-summary (ECG (summary))is related toekg-lt-cvdmapping.md already covered — ECG. EKGLtCvd. Example: observation-ekg-normal-example.
ac-medication-context (Medications (context))is related tomedication-statement-lt-cvdMedicationStatementLtCvd. Example: medication-statement-screening-example.
ac-diabetes-duration (Diabetes duration)is related todiabetes-duration-status-lt-cvdDiabetesDurationStatusLtCvd. Example: observation-diabetes-duration-gt10-example.

Lithuanian

Generated Narrative: ConceptMap conceptmap-cvd-risk-assessment-questionnaire

Language: en

Mapping from (not specified) to (not specified)


Group 1 Mapping from CVD risk assessment questionnaire item (linkId)version: 0.1.0) to CVD questionnaire mapping target (profiles)version: 0.1.0)

Source CodeRelationshipTarget CodeComment
grp-context (Context group)is related toobservation-lt (ObservationLt (LT Base))Section header. Registrar, institution, and workstation context typically use LT Base Patient, Practitioner, Organization, and PractitionerRole (not itemised in the illustrative Questionnaire). LT Base IG: https://hl7.lt/fhir/base/ImplementationGuide/lt.hl7.fhir.base
evaluation-datetime (Evaluation date and time)is related tocvd-risk-assessment-lt-cvdAligns with Observation.effectiveDateTime on CVDRiskAssessmentLtCvd. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/cvd-risk-assessment-lt-cvd. Example: observation-cvd-risk-assessment-example. CVD IG: https://hl7.lt/fhir/cvd/ImplementationGuide/lt.hl7.fhir.cvd
grp-chronic (Accompanying chronic diseases)is related tocvd-chronic-condition-lt-cvdSection header for accompanying chronic diseases; child items use CvdChronicConditionLtCvd.
chronic-condition-summary (Chronic conditions summary)is related tocvd-chronic-condition-lt-cvdMap programme text to Condition with CvdChronicConditionLtCvd (ICD-10). StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/cvd-chronic-condition-lt-cvd. Example: condition-cvd-heart-failure-example.
grp-risk-factors (Risk factors)is related torisk-factor-status-lt-cvdSection header for programme risk-factor items (RiskFactorStatusLtCvd).
risk-factor-hypertension (Arterial hypertension)is related torisk-factor-status-lt-cvdRiskFactorStatusLtCvd. Example: observation-hypertension-negligible-example. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/risk-factor-status-lt-cvd
risk-factor-dyslipidemia (Dyslipidemia)is related torisk-factor-status-lt-cvdRiskFactorStatusLtCvd. Example: observation-dyslipidemia-treated-example.
risk-factor-diabetes (Diabetes)is related torisk-factor-status-lt-cvdRiskFactorStatusLtCvd. Example: observation-diabetes-untreated-example.
risk-factor-smoking (Smoking)is related totobacco-use-lt-lifestyleTobaccoUseLtLifestyle (LT Lifestyle). StructureDefinition: https://hl7.lt/fhir/lifestyle/StructureDefinition/tobacco-use-lt-lifestyle. CI example: https://build.fhir.org/ig/HL7LT/ig-lt-lifestyle/Observation-observation-tobacco-use-current-smoker-example.html
grp-objective (Objective condition and investigations)is related tobody-height (BodyHeight (Vital Signs))Section header for anthropometrics and blood pressure (LT Vital Signs IG). See child items for BodyHeight, BodyWeight, WaistCircumference, BloodPressurePanel. Vital Signs IG: https://hl7.lt/fhir/vitalsigns/ImplementationGuide/lt.hl7.fhir.vitalsigns
height-cm (Height (cm))is related tobody-height (BodyHeight (Vital Signs))BodyHeight. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/body-height. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-body-height-example.html
weight-kg (Weight (kg))is related tobody-weight (BodyWeight (Vital Signs))BodyWeight. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/body-weight. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-body-weight-example.html
waist-cm (Waist circumference (cm))is related towaist-circumference (WaistCircumference (Vital Signs))WaistCircumference. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/waist-circumference. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-waist-circumference-example.html
bp-systolic (Systolic blood pressure (mmHg))is related toblood-pressure-panel (BloodPressurePanel (Vital Signs))BloodPressurePanel (systolic component). StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/blood-pressure-panel. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-blood-pressure-example.html
bp-diastolic (Diastolic blood pressure (mmHg))is related toblood-pressure-panel (BloodPressurePanel (Vital Signs))BloodPressurePanel (diastolic component); same Observation as systolic.
grp-lipidogram (Lipidogram)is related tolipidogram-lab-ltLipid panel section. Composite lab example: observation-lipidogram-example. Lab IG: https://hl7.lt/fhir/lab/ImplementationGuide/lt.hl7.fhir.lab. CI: https://build.fhir.org/ig/HL7LT/ig-lt-lab/Observation-observation-lipidogram-example.html
lipid-tc (Total cholesterol (mmol/l))is related tototal-cholesterol-lab-ltTotalCholesterolLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/total-cholesterol-lab-lt. Same CI lipidogram example as other lipid items.
lipid-hdl (HDL cholesterol (mmol/l))is related tocholesterol-hdl-lab-ltCholesterolHdlLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/cholesterol-hdl-lab-lt.
lipid-ldl (LDL cholesterol (mmol/l))is related tocholesterol-ldl-lab-ltCholesterolLdlLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/cholesterol-ldl-lab-lt.
lipid-tg (Triglycerides (mmol/l))is related totriglycerides-lab-ltTriglyceridesLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/triglycerides-lab-lt.
grp-risk-estimate (Risk estimate and group)is related tocvd-risk-assessment-lt-cvdSection for SCORE2 and programme risk group (CVD IG).
score2-percent (SCORE2 cardiovascular risk (%))is related tocvd-risk-assessment-lt-cvdSCORE2 as valueQuantity (%). CVDRiskAssessmentLtCvd. Example: observation-cvd-risk-assessment-example.
risk-group-cvd (Risk group for heart and vascular diseases)is related torisk-group-observation-lt-cvdRiskGroupObservationLtCvd. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/risk-group-observation-lt-cvd. Example: observation-risk-group-high-example.
grp-migration-md-parity (Migration mapping.md — extended parity)is related toobservation-lt (ObservationLt (LT Base))Section for input/fsh/migration/mapping.md parity: concepts listed as missing in sibling IGs or as extended investigations. Rows 3–12,16–17 (BP, vitals, lipids, smoking) are covered by sibling items above.
mig-encounter (Encounter (visit context))is related toencounter-lt (EncounterLt (LT Base))mapping.md row 1 — Encounter. StructureDefinition: https://hl7.lt/fhir/base/StructureDefinition/encounter-lt. Base example: encounter-psychiatric-example.
mig-practitioner-role (PractitionerRole (workplace))is related topractitioner-role-lt (PractitionerRoleLt (LT Base))mapping.md row 2 — PractitionerRole. StructureDefinition: https://hl7.lt/fhir/base/StructureDefinition/practitioner-role-lt. Example: practitioner-role-doctor-vilnius-hospital-example.
mig-heart-rate (Heart rate (bpm))is related toheart-rate (HeartRate (Vital Signs))mapping.md row 4 — Heart rate. Vital Signs heart-rate profile. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/
mig-bmi (BMI (kg/m²))is related tobmi (BMI (Vital Signs))mapping.md row 7 — BMI. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/bmi
mig-glucose-fasting (Fasting glucose (mmol/l))is related toglucose-venous-lab-ltmapping.md row 13 — Fasting glucose. Lab: glucose-venous-lab-lt.
mig-hba1c (HbA1c (%))is related tohba1c-lab-ltmapping.md row 14 — HbA1c. Lab: hba1c-lab-lt.
mig-creatinine (Creatinine)is related tocreatinine-test-lab-ltmapping.md row 15 — Creatinine. Lab: creatinine-test-lab-lt.
mig-egfr (eGFR)is related toegfr-lab-ltmapping.md row 15 — eGFR. Lab: egfr-lab-lt.
mig-alcohol (Alcohol consumption)is related toalcohol-consumption-lt-lifestylemapping.md row 18 — Alcohol. Lifestyle: alcohol-consumption-lt-lifestyle.
mig-physical-activity (Physical activity (summary))is related tophysical-activity-lt-lifestylemapping.md row 19 — Physical activity. Lifestyle: physical-activity-lt-lifestyle.
mig-nutrition (Dietary habits / nutrition)is related tonutrition-lt-lifestylemapping.md row 20 — Dietary habits. Lifestyle: nutrition-lt-lifestyle.
mig-family-cvd (Family history of CVD)is related tofamily-history-cvd-lt-lifestylemapping.md row 21 — Family CVD history. Lifestyle: family-history-cvd-lt-lifestyle.
mig-referral (Referral)is related toservice-request-lt (ServiceRequestLt (LT Base))mapping.md row 22 — Referral. Base ServiceRequestLt (no example in IGs; profile only).
mig-follow-up-appointment (Follow-up visit / appointment)is related toappointment-lt (AppointmentLt (LT Base))mapping.md row 23 — Follow-up visit. Base AppointmentLt (no example in IGs; profile only).
mig-achievement-round (Achievement evaluation (narrative))is related toobservation-lt (ObservationLt (LT Base))mapping.md row 24 — Achievement evaluation at second timepoint; use prevention Questionnaire achievement group or repeat vitals/labs/lifestyle Observations.
mig-chronic-additional (Additional chronic conditions)is related tocvd-chronic-condition-lt-cvdmapping.md row 25 — Additional chronic conditions (depression, COPD, AF, …). CvdChronicConditionLtCvd.
grp-ig-example-parity (IG example parity (migration already-covered))is related toobservation-lt (ObservationLt (LT Base))Section for migration already-covered table: context notes and EKG/medication/diabetes duration.
ac-patient-context (Patient (context note))is related topatient-lt (PatientLt (LT Base))Maps to PatientLt; QuestionnaireResponse.subject typically carries the Patient. Example: patient-male-example.
ac-practitioner-context (Practitioner (context note))is related topractitioner-lt (PractitionerLt (LT Base))Maps to PractitionerLt; QuestionnaireResponse.author. Example: practitioner-example.
ac-organization-context (Organization (context note))is related toorganization-lt (OrganizationLt (LT Base))Maps to OrganizationLt; use context in CarePlan/Encounter. Example: organization-example.
ac-ekg-summary (ECG (summary))is related toekg-lt-cvdmapping.md already covered — ECG. EKGLtCvd. Example: observation-ekg-normal-example.
ac-medication-context (Medications (context))is related tomedication-statement-lt-cvdMedicationStatementLtCvd. Example: medication-statement-screening-example.
ac-diabetes-duration (Diabetes duration)is related todiabetes-duration-status-lt-cvdDiabetesDurationStatusLtCvd. Example: observation-diabetes-duration-gt10-example.
"},"url":"https://hl7.lt/fhir/cvd/ConceptMap/cvd-risk-assessment-questionnaire","version":"0.1.0","name":"CvdRiskAssessmentQuestionnaireItemMap","title":"CVD risk assessment questionnaire item to profile mapping","status":"draft","experimental":true,"date":"2025-10-01","publisher":"Lithuanian Medical Library","contact":[{"name":"Lithuanian Medical Library","telecom":[{"system":"url","value":"https://medicinosnk.lt"},{"system":"email","value":"info@medicinosnk.lt"}]}],"description":"Maps ESPBI form 1 Questionnaire linkIds to Lithuanian FHIR profiles and related IGs. \nHuman-readable narrative is in each target.comment; Questionnaire.item.definition repeats canonical StructureDefinition URIs where applicable. \nSource: linkId codes; target: profile identifiers (CodeSystem cvd-questionnaire-mapping-target).\n\nAligned with DSTU1 data structures.\n\nIn DSTU1, the CarePlan used inline `` elements with extensions for target values and\n`` elements for lifestyle interventions. In R5:\n\n- **Goals** are referenced via `CarePlan.goal` pointing to standalone `Goal` resources\n (or contained inline). Goal types: LDL target, BP target, BMI target, weight loss ≥5%.\n- **Activities** use `CarePlan.activity.plannedActivityReference` for structured references\n or `CarePlan.activity.performedActivity` for completed activities.\n- **Risk group** moved from DSTU1 inline Observation to an extension on CarePlan.\n- **Informational text** (healthy nutrition, healthy weight, regular medication) is carried\n in `CarePlan.note` or `CarePlan.supportingInfo.display`.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"LT"}]}],"group":[{"source":"https://hl7.lt/fhir/cvd/CodeSystem/cvd-questionnaire-risk-assessment-item|0.1.0","target":"https://hl7.lt/fhir/cvd/CodeSystem/cvd-questionnaire-mapping-target|0.1.0","element":[{"code":"grp-context","display":"Context group","target":[{"code":"observation-lt","display":"ObservationLt (LT Base)","relationship":"related-to","comment":"Section header. Registrar, institution, and workstation context typically use LT Base Patient, Practitioner, Organization, and PractitionerRole (not itemised in the illustrative Questionnaire). LT Base IG: https://hl7.lt/fhir/base/ImplementationGuide/lt.hl7.fhir.base"}]},{"code":"evaluation-datetime","target":[{"code":"cvd-risk-assessment-lt-cvd","relationship":"related-to","comment":"Aligns with Observation.effectiveDateTime on CVDRiskAssessmentLtCvd. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/cvd-risk-assessment-lt-cvd. Example: observation-cvd-risk-assessment-example. CVD IG: https://hl7.lt/fhir/cvd/ImplementationGuide/lt.hl7.fhir.cvd"}]},{"code":"grp-chronic","target":[{"code":"cvd-chronic-condition-lt-cvd","relationship":"related-to","comment":"Section header for accompanying chronic diseases; child items use CvdChronicConditionLtCvd."}]},{"code":"chronic-condition-summary","target":[{"code":"cvd-chronic-condition-lt-cvd","relationship":"related-to","comment":"Map programme text to Condition with CvdChronicConditionLtCvd (ICD-10). StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/cvd-chronic-condition-lt-cvd. Example: condition-cvd-heart-failure-example."}]},{"code":"grp-risk-factors","target":[{"code":"risk-factor-status-lt-cvd","relationship":"related-to","comment":"Section header for programme risk-factor items (RiskFactorStatusLtCvd)."}]},{"code":"risk-factor-hypertension","target":[{"code":"risk-factor-status-lt-cvd","relationship":"related-to","comment":"RiskFactorStatusLtCvd. Example: observation-hypertension-negligible-example. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/risk-factor-status-lt-cvd"}]},{"code":"risk-factor-dyslipidemia","target":[{"code":"risk-factor-status-lt-cvd","relationship":"related-to","comment":"RiskFactorStatusLtCvd. Example: observation-dyslipidemia-treated-example."}]},{"code":"risk-factor-diabetes","target":[{"code":"risk-factor-status-lt-cvd","relationship":"related-to","comment":"RiskFactorStatusLtCvd. Example: observation-diabetes-untreated-example."}]},{"code":"risk-factor-smoking","target":[{"code":"tobacco-use-lt-lifestyle","relationship":"related-to","comment":"TobaccoUseLtLifestyle (LT Lifestyle). StructureDefinition: https://hl7.lt/fhir/lifestyle/StructureDefinition/tobacco-use-lt-lifestyle. CI example: https://build.fhir.org/ig/HL7LT/ig-lt-lifestyle/Observation-observation-tobacco-use-current-smoker-example.html"}]},{"code":"grp-objective","target":[{"code":"body-height","relationship":"related-to","comment":"Section header for anthropometrics and blood pressure (LT Vital Signs IG). See child items for BodyHeight, BodyWeight, WaistCircumference, BloodPressurePanel. Vital Signs IG: https://hl7.lt/fhir/vitalsigns/ImplementationGuide/lt.hl7.fhir.vitalsigns"}]},{"code":"height-cm","target":[{"code":"body-height","relationship":"related-to","comment":"BodyHeight. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/body-height. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-body-height-example.html"}]},{"code":"weight-kg","target":[{"code":"body-weight","relationship":"related-to","comment":"BodyWeight. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/body-weight. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-body-weight-example.html"}]},{"code":"waist-cm","target":[{"code":"waist-circumference","relationship":"related-to","comment":"WaistCircumference. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/waist-circumference. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-waist-circumference-example.html"}]},{"code":"bp-systolic","target":[{"code":"blood-pressure-panel","relationship":"related-to","comment":"BloodPressurePanel (systolic component). StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/blood-pressure-panel. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-blood-pressure-example.html"}]},{"code":"bp-diastolic","target":[{"code":"blood-pressure-panel","relationship":"related-to","comment":"BloodPressurePanel (diastolic component); same Observation as systolic."}]},{"code":"grp-lipidogram","target":[{"code":"lipidogram-lab-lt","relationship":"related-to","comment":"Lipid panel section. Composite lab example: observation-lipidogram-example. Lab IG: https://hl7.lt/fhir/lab/ImplementationGuide/lt.hl7.fhir.lab. CI: https://build.fhir.org/ig/HL7LT/ig-lt-lab/Observation-observation-lipidogram-example.html"}]},{"code":"lipid-tc","target":[{"code":"total-cholesterol-lab-lt","relationship":"related-to","comment":"TotalCholesterolLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/total-cholesterol-lab-lt. Same CI lipidogram example as other lipid items."}]},{"code":"lipid-hdl","target":[{"code":"cholesterol-hdl-lab-lt","relationship":"related-to","comment":"CholesterolHdlLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/cholesterol-hdl-lab-lt."}]},{"code":"lipid-ldl","target":[{"code":"cholesterol-ldl-lab-lt","relationship":"related-to","comment":"CholesterolLdlLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/cholesterol-ldl-lab-lt."}]},{"code":"lipid-tg","target":[{"code":"triglycerides-lab-lt","relationship":"related-to","comment":"TriglyceridesLabLt. StructureDefinition: https://hl7.lt/fhir/lab/StructureDefinition/triglycerides-lab-lt."}]},{"code":"grp-risk-estimate","target":[{"code":"cvd-risk-assessment-lt-cvd","relationship":"related-to","comment":"Section for SCORE2 and programme risk group (CVD IG)."}]},{"code":"score2-percent","target":[{"code":"cvd-risk-assessment-lt-cvd","relationship":"related-to","comment":"SCORE2 as valueQuantity (%). CVDRiskAssessmentLtCvd. Example: observation-cvd-risk-assessment-example."}]},{"code":"risk-group-cvd","target":[{"code":"risk-group-observation-lt-cvd","relationship":"related-to","comment":"RiskGroupObservationLtCvd. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/risk-group-observation-lt-cvd. Example: observation-risk-group-high-example."}]},{"code":"grp-migration-md-parity","target":[{"code":"observation-lt","relationship":"related-to","comment":"Section for input/fsh/migration/mapping.md parity: concepts listed as missing in sibling IGs or as extended investigations. Rows 3–12,16–17 (BP, vitals, lipids, smoking) are covered by sibling items above."}]},{"code":"mig-encounter","target":[{"code":"encounter-lt","relationship":"related-to","comment":"mapping.md row 1 — Encounter. StructureDefinition: https://hl7.lt/fhir/base/StructureDefinition/encounter-lt. Base example: encounter-psychiatric-example."}]},{"code":"mig-practitioner-role","target":[{"code":"practitioner-role-lt","relationship":"related-to","comment":"mapping.md row 2 — PractitionerRole. StructureDefinition: https://hl7.lt/fhir/base/StructureDefinition/practitioner-role-lt. Example: practitioner-role-doctor-vilnius-hospital-example."}]},{"code":"mig-heart-rate","target":[{"code":"heart-rate","relationship":"related-to","comment":"mapping.md row 4 — Heart rate. Vital Signs heart-rate profile. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/"}]},{"code":"mig-bmi","target":[{"code":"bmi","relationship":"related-to","comment":"mapping.md row 7 — BMI. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/bmi"}]},{"code":"mig-glucose-fasting","target":[{"code":"glucose-venous-lab-lt","relationship":"related-to","comment":"mapping.md row 13 — Fasting glucose. Lab: glucose-venous-lab-lt."}]},{"code":"mig-hba1c","target":[{"code":"hba1c-lab-lt","relationship":"related-to","comment":"mapping.md row 14 — HbA1c. Lab: hba1c-lab-lt."}]},{"code":"mig-creatinine","target":[{"code":"creatinine-test-lab-lt","relationship":"related-to","comment":"mapping.md row 15 — Creatinine. Lab: creatinine-test-lab-lt."}]},{"code":"mig-egfr","target":[{"code":"egfr-lab-lt","relationship":"related-to","comment":"mapping.md row 15 — eGFR. Lab: egfr-lab-lt."}]},{"code":"mig-alcohol","target":[{"code":"alcohol-consumption-lt-lifestyle","relationship":"related-to","comment":"mapping.md row 18 — Alcohol. Lifestyle: alcohol-consumption-lt-lifestyle."}]},{"code":"mig-physical-activity","target":[{"code":"physical-activity-lt-lifestyle","relationship":"related-to","comment":"mapping.md row 19 — Physical activity. Lifestyle: physical-activity-lt-lifestyle."}]},{"code":"mig-nutrition","target":[{"code":"nutrition-lt-lifestyle","relationship":"related-to","comment":"mapping.md row 20 — Dietary habits. Lifestyle: nutrition-lt-lifestyle."}]},{"code":"mig-family-cvd","target":[{"code":"family-history-cvd-lt-lifestyle","relationship":"related-to","comment":"mapping.md row 21 — Family CVD history. Lifestyle: family-history-cvd-lt-lifestyle."}]},{"code":"mig-referral","target":[{"code":"service-request-lt","relationship":"related-to","comment":"mapping.md row 22 — Referral. Base ServiceRequestLt (no example in IGs; profile only)."}]},{"code":"mig-follow-up-appointment","target":[{"code":"appointment-lt","relationship":"related-to","comment":"mapping.md row 23 — Follow-up visit. Base AppointmentLt (no example in IGs; profile only)."}]},{"code":"mig-achievement-round","target":[{"code":"observation-lt","relationship":"related-to","comment":"mapping.md row 24 — Achievement evaluation at second timepoint; use prevention Questionnaire achievement group or repeat vitals/labs/lifestyle Observations."}]},{"code":"mig-chronic-additional","target":[{"code":"cvd-chronic-condition-lt-cvd","relationship":"related-to","comment":"mapping.md row 25 — Additional chronic conditions (depression, COPD, AF, …). CvdChronicConditionLtCvd."}]},{"code":"grp-ig-example-parity","target":[{"code":"observation-lt","relationship":"related-to","comment":"Section for migration already-covered table: context notes and EKG/medication/diabetes duration."}]},{"code":"ac-patient-context","target":[{"code":"patient-lt","relationship":"related-to","comment":"Maps to PatientLt; QuestionnaireResponse.subject typically carries the Patient. Example: patient-male-example."}]},{"code":"ac-practitioner-context","target":[{"code":"practitioner-lt","relationship":"related-to","comment":"Maps to PractitionerLt; QuestionnaireResponse.author. Example: practitioner-example."}]},{"code":"ac-organization-context","target":[{"code":"organization-lt","relationship":"related-to","comment":"Maps to OrganizationLt; use context in CarePlan/Encounter. Example: organization-example."}]},{"code":"ac-ekg-summary","target":[{"code":"ekg-lt-cvd","relationship":"related-to","comment":"mapping.md already covered — ECG. EKGLtCvd. Example: observation-ekg-normal-example."}]},{"code":"ac-medication-context","target":[{"code":"medication-statement-lt-cvd","relationship":"related-to","comment":"MedicationStatementLtCvd. Example: medication-statement-screening-example."}]},{"code":"ac-diabetes-duration","target":[{"code":"diabetes-duration-status-lt-cvd","relationship":"related-to","comment":"DiabetesDurationStatusLtCvd. Example: observation-diabetes-duration-gt10-example."}]}]}]}},{"fullUrl":"ConceptMap/snomed_implicit_map_900000000000523009","resource":{"resourceType":"ConceptMap","id":"snomed_implicit_map_900000000000523009","text":{"status":"generated","div":"
This SNOMED CT Implicit Concept Map from http://snomed.info/sct?fhir_vs to http://snomed.info/sct?fhir_vs is generated using Reference Set 900000000000523009.
"},"url":"http://snomed.info/sct?fhir_cm=900000000000523009","name":"POSSIBLY EQUIVALENT TO"}},{"fullUrl":"ConceptMap/conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate","resource":{"resourceType":"ConceptMap","id":"conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate","language":"en","text":{"status":"generated","div":"

English

Generated Narrative: ConceptMap conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate

Language: en

Mapping from (not specified) to (not specified)


Group 1 Mapping from Prostate pathology ESPBI Questionnaire item (linkId)version: 0.0.1) to Prostate questionnaire → FHIR mapping target (illustrative)version: 0.0.1)

Source CodeRelationshipTarget CodeComment
bioptate-length-mm (Bioptate length (mm))is related tospecimen-dimension-or-measurement (Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross))Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab).
specimen-quality (Quality of materials)is related tospecimen-adequacy-finding (Observation: specimen adequacy (LT Lab))Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec.
treatment-effect (Treatment effect on tumour)is related toobservation-tumor-treatment-effect (Observation: tumor treatment effect (TumorObservableLtLab))TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet.
histological-type (Primary histological type)is related tocondition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging.
histological-comment (Histological type comment)is related tocondition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))Condition.note or Observation.note; complements histological-type.
isup-grade-groupis related toobservation-gleason-isup-prostate (GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS)GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example.
idc-status (Intraductal carcinoma (IDC))is related toobservation-tumor-microscopic-idc (TumorObservableLtLab / morphology for IDC)TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions.
cribriform-status (Cribriform glands)is related toobservation-tumor-microscopic-cribriform (TumorObservableLtLab / morphology for cribriform)TumorObservableLtLab or structured finding Observation.
pattern4-pct-band (Pattern 4 quantity (percent band))is related toobservation-pattern4-percent (Observation: Pattern 4 percent band (lab tumour measurement patterns))TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire.
tumor-percent-in-biopsy (Tumour percentage in biopsy tissue)is related toobservation-tumor-burden-percent (Observation: tumour percentage in biopsy tissue)Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category.
periprostatic-fat-invasionis related toobservation-periprostatic-invasion (Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings))NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy.
perineural-invasionis related toobservation-perineural-invasion (Observation: perineural invasion finding (LT Lab tumour findings))SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings.
lymphovascular-invasion (Lymphatic and/or vascular tumour invasion)is related toobservation-lymphovascular-invasion (Observation: lymphovascular invasion finding (LT Lab tumour findings))SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment.

Lithuanian

Generated Narrative: ConceptMap conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate

Language: en

Mapping from (not specified) to (not specified)


Group 1 Mapping from Prostate pathology ESPBI Questionnaire item (linkId)version: 0.0.1) to Prostate questionnaire → FHIR mapping target (illustrative)version: 0.0.1)

Source CodeRelationshipTarget CodeComment
bioptate-length-mm (Bioptate length (mm))is related tospecimen-dimension-or-measurement (Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross))Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab).
specimen-quality (Quality of materials)is related tospecimen-adequacy-finding (Observation: specimen adequacy (LT Lab))Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec.
treatment-effect (Treatment effect on tumour)is related toobservation-tumor-treatment-effect (Observation: tumor treatment effect (TumorObservableLtLab))TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet.
histological-type (Primary histological type)is related tocondition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging.
histological-comment (Histological type comment)is related tocondition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))Condition.note or Observation.note; complements histological-type.
isup-grade-groupis related toobservation-gleason-isup-prostate (GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS)GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example.
idc-status (Intraductal carcinoma (IDC))is related toobservation-tumor-microscopic-idc (TumorObservableLtLab / morphology for IDC)TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions.
cribriform-status (Cribriform glands)is related toobservation-tumor-microscopic-cribriform (TumorObservableLtLab / morphology for cribriform)TumorObservableLtLab or structured finding Observation.
pattern4-pct-band (Pattern 4 quantity (percent band))is related toobservation-pattern4-percent (Observation: Pattern 4 percent band (lab tumour measurement patterns))TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire.
tumor-percent-in-biopsy (Tumour percentage in biopsy tissue)is related toobservation-tumor-burden-percent (Observation: tumour percentage in biopsy tissue)Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category.
periprostatic-fat-invasionis related toobservation-periprostatic-invasion (Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings))NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy.
perineural-invasionis related toobservation-perineural-invasion (Observation: perineural invasion finding (LT Lab tumour findings))SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings.
lymphovascular-invasion (Lymphatic and/or vascular tumour invasion)is related toobservation-lymphovascular-invasion (Observation: lymphovascular invasion finding (LT Lab tumour findings))SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment.
"},"url":"https://hl7.lt/fhir/prostate/ConceptMap/prostate-pathology-questionnaire-to-fhir","version":"0.1.0","name":"ProstatePathologyQuestionnaireToFhir","title":"Prostate pathology Questionnaire items to FHIR mapping","status":"draft","experimental":true,"date":"2025-03-24","publisher":"Lithuanian Medical Library","contact":[{"name":"Lithuanian Medical Library","telecom":[{"system":"url","value":"https://medicinosnk.lt"},{"system":"email","value":"info@medicinosnk.lt"}]}],"description":"Maps dr-prostate-aligned pathology Questionnaire linkIds to LT Lab and LT Prostate Gleason/ISUP patterns.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"LT"}]}],"group":[{"source":"https://tx.hl7.lt/fhir/CodeSystem/prostate-pathology-questionnaire-item|0.0.1","target":"https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target|0.0.1","element":[{"code":"bioptate-length-mm","display":"Bioptate length (mm)","target":[{"code":"specimen-dimension-or-measurement","relationship":"related-to","comment":"Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab)."}]},{"code":"specimen-quality","display":"Quality of materials","target":[{"code":"specimen-adequacy-finding","relationship":"related-to","comment":"Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec."}]},{"code":"treatment-effect","display":"Treatment effect on tumour","target":[{"code":"observation-tumor-treatment-effect","relationship":"related-to","comment":"TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet."}]},{"code":"histological-type","display":"Primary histological type","target":[{"code":"condition-morphology-prostate","relationship":"related-to","comment":"Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging."}]},{"code":"histological-comment","display":"Histological type comment","target":[{"code":"condition-morphology-prostate","relationship":"related-to","comment":"Condition.note or Observation.note; complements histological-type."}]},{"code":"isup-grade-group","display":"ISUP grade group","target":[{"code":"observation-gleason-isup-prostate","relationship":"related-to","comment":"GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example."}]},{"code":"idc-status","display":"Intraductal carcinoma (IDC)","target":[{"code":"observation-tumor-microscopic-idc","relationship":"related-to","comment":"TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions."}]},{"code":"cribriform-status","display":"Cribriform glands","target":[{"code":"observation-tumor-microscopic-cribriform","relationship":"related-to","comment":"TumorObservableLtLab or structured finding Observation."}]},{"code":"pattern4-pct-band","display":"Pattern 4 quantity (percent band)","target":[{"code":"observation-pattern4-percent","relationship":"related-to","comment":"TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire."}]},{"code":"tumor-percent-in-biopsy","display":"Tumour percentage in biopsy tissue","target":[{"code":"observation-tumor-burden-percent","relationship":"related-to","comment":"Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category."}]},{"code":"periprostatic-fat-invasion","display":"Periprostatic fat invasion","target":[{"code":"observation-periprostatic-invasion","relationship":"related-to","comment":"NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy."}]},{"code":"perineural-invasion","display":"Perineural invasion","target":[{"code":"observation-perineural-invasion","relationship":"related-to","comment":"SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings."}]},{"code":"lymphovascular-invasion","display":"Lymphatic and/or vascular tumour invasion","target":[{"code":"observation-lymphovascular-invasion","relationship":"related-to","comment":"SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment."}]}]}]}},{"fullUrl":"ConceptMap/snomed_implicit_map_446608001","resource":{"resourceType":"ConceptMap","id":"snomed_implicit_map_446608001","text":{"status":"generated","div":"
This SNOMED CT Implicit Concept Map from http://snomed.info/sct?fhir_vs to http://hl7.org/fhir/sid/icd-o?fhir_vs is generated using Reference Set 446608001.
"},"url":"http://snomed.info/sct?fhir_cm=446608001","name":"SNOMED CT to ICD-O simple map"}},{"fullUrl":"ConceptMap/snomed_implicit_map_900000000000527005","resource":{"resourceType":"ConceptMap","id":"snomed_implicit_map_900000000000527005","text":{"status":"generated","div":"
This SNOMED CT Implicit Concept Map from http://snomed.info/sct?fhir_vs to http://snomed.info/sct?fhir_vs is generated using Reference Set 900000000000527005.
"},"url":"http://snomed.info/sct?fhir_cm=900000000000527005","name":"SAME AS"}},{"fullUrl":"ConceptMap/conceptmap-cvd-prevention-plan-questionnaire","resource":{"resourceType":"ConceptMap","id":"conceptmap-cvd-prevention-plan-questionnaire","language":"en","text":{"status":"generated","div":"

English

Generated Narrative: ConceptMap conceptmap-cvd-prevention-plan-questionnaire

Language: en

Mapping from (not specified) to (not specified)


Group 1 Mapping from CVD prevention plan questionnaire item (linkId)version: 0.1.0) to CVD questionnaire mapping target (profiles)version: 0.1.0)

Source CodeRelationshipTarget CodeComment
grp-plan-header (Plan header)is related tocare-plan-lt-cvdSection header for plan metadata, risk group, LDL target, and smoking cessation (CarePlanLtCvd). Example: care-plan-cvd-screening-example. CVD IG: https://hl7.lt/fhir/cvd/ImplementationGuide/lt.hl7.fhir.cvd
plan-created-datetime (Plan creation date and time)is related tocare-plan-lt-cvdCarePlan.created / period on CarePlanLtCvd. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/care-plan-lt-cvd. Example: care-plan-cvd-screening-example.
plan-risk-group (Risk group (plan))is related torisk-group-ext-lt-cvdRisk group on the plan: RiskGroupExtLtCvd on CarePlan and/or persisted RiskGroupObservationLtCvd. Extension: https://hl7.lt/fhir/cvd/StructureDefinition/risk-group-ext-lt-cvd. Example observation: observation-risk-group-high-example.
plan-target-ldl (Target LDL cholesterol)is related tocare-plan-lt-cvdTarget LDL as CarePlan.goal (e.g. LOINC 18262-6) on CarePlanLtCvd; compare to CholesterolLdlLabLt at follow-up. Lab profile: https://hl7.lt/fhir/lab/StructureDefinition/cholesterol-ldl-lab-lt
plan-smoking-cessation (Quitting smoking (interventions))is related tocare-plan-lt-cvdCarePlan.activity for cessation interventions; related behaviour may appear as TobaccoUseLtLifestyle. Lifestyle: https://hl7.lt/fhir/lifestyle/StructureDefinition/tobacco-use-lt-lifestyle
grp-plan-lifestyle (Lifestyle and weight)is related tophysical-activity-lt-lifestyleSection header for lifestyle and weight (physical activity, target BMI).
plan-physical-activity (Physical activity plan)is related tophysical-activity-lt-lifestylePhysicalActivityLtLifestyle. StructureDefinition: https://hl7.lt/fhir/lifestyle/StructureDefinition/physical-activity-lt-lifestyle. CI: https://build.fhir.org/ig/HL7LT/ig-lt-lifestyle/Observation-observation-physical-activity-below-example.html
plan-target-bmi (Target BMI (kg/m²))is related tobmi (BMI (Vital Signs))Target BMI as goal on CarePlan; measured BMI uses vitalsigns BMI profile. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/bmi
grp-achievement (Achievement evaluation)is related toobservation-lt (ObservationLt (LT Base))Achievement evaluation section; aligns with follow-up Observations in this IG (e.g. observation-cvd-followup-*). CVD IG examples bundle with CvdReportLtCvd / CvdCompositionLtCvd as appropriate.
achievement-datetime (Achievement evaluation date and time)is related toobservation-lt (ObservationLt (LT Base))Effective time on follow-up Observations or encounter context. Base profile: https://hl7.lt/fhir/base/StructureDefinition/observation-lt. LT Base IG: https://hl7.lt/fhir/base/ImplementationGuide/lt.hl7.fhir.base
achievement-ldl-mmol (Achieved LDL cholesterol (mmol/l))is related tocholesterol-ldl-lab-ltAchieved LDL: CholesterolLdlLabLt. CI lipidogram: https://build.fhir.org/ig/HL7LT/ig-lt-lab/Observation-observation-lipidogram-example.html
achievement-ldl-target-met (Target LDL achieved (boolean))is related tocare-plan-lt-cvdInterpret against CarePlan LDL goals and latest CholesterolLdlLabLt Observation.
achievement-bp-systolic (Current systolic BP (mmHg))is related toblood-pressure-panel (BloodPressurePanel (Vital Signs))BloodPressurePanel systolic component. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-blood-pressure-example.html
achievement-bp-diastolic (Current diastolic BP (mmHg))is related toblood-pressure-panel (BloodPressurePanel (Vital Signs))BloodPressurePanel diastolic component; same Observation as systolic.
achievement-bp-target-met (Target BP achieved (boolean))is related tocare-plan-lt-cvdInterpret against CarePlan BP goals and BloodPressurePanel Observations.
achievement-comments (Achievement evaluator comments)is related toobservation-lt (ObservationLt (LT Base))Free-text comments; may appear as note on ObservationLt or related resource. StructureDefinition: https://hl7.lt/fhir/base/StructureDefinition/observation-lt
achievement-smoking-quit (Smoking cessation achieved)is related totobacco-use-lt-lifestylemapping.md row 24 — Smoking cessation at achievement; TobaccoUseLtLifestyle vs plan smoking cessation items.

Lithuanian

Generated Narrative: ConceptMap conceptmap-cvd-prevention-plan-questionnaire

Language: en

Mapping from (not specified) to (not specified)


Group 1 Mapping from CVD prevention plan questionnaire item (linkId)version: 0.1.0) to CVD questionnaire mapping target (profiles)version: 0.1.0)

Source CodeRelationshipTarget CodeComment
grp-plan-header (Plan header)is related tocare-plan-lt-cvdSection header for plan metadata, risk group, LDL target, and smoking cessation (CarePlanLtCvd). Example: care-plan-cvd-screening-example. CVD IG: https://hl7.lt/fhir/cvd/ImplementationGuide/lt.hl7.fhir.cvd
plan-created-datetime (Plan creation date and time)is related tocare-plan-lt-cvdCarePlan.created / period on CarePlanLtCvd. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/care-plan-lt-cvd. Example: care-plan-cvd-screening-example.
plan-risk-group (Risk group (plan))is related torisk-group-ext-lt-cvdRisk group on the plan: RiskGroupExtLtCvd on CarePlan and/or persisted RiskGroupObservationLtCvd. Extension: https://hl7.lt/fhir/cvd/StructureDefinition/risk-group-ext-lt-cvd. Example observation: observation-risk-group-high-example.
plan-target-ldl (Target LDL cholesterol)is related tocare-plan-lt-cvdTarget LDL as CarePlan.goal (e.g. LOINC 18262-6) on CarePlanLtCvd; compare to CholesterolLdlLabLt at follow-up. Lab profile: https://hl7.lt/fhir/lab/StructureDefinition/cholesterol-ldl-lab-lt
plan-smoking-cessation (Quitting smoking (interventions))is related tocare-plan-lt-cvdCarePlan.activity for cessation interventions; related behaviour may appear as TobaccoUseLtLifestyle. Lifestyle: https://hl7.lt/fhir/lifestyle/StructureDefinition/tobacco-use-lt-lifestyle
grp-plan-lifestyle (Lifestyle and weight)is related tophysical-activity-lt-lifestyleSection header for lifestyle and weight (physical activity, target BMI).
plan-physical-activity (Physical activity plan)is related tophysical-activity-lt-lifestylePhysicalActivityLtLifestyle. StructureDefinition: https://hl7.lt/fhir/lifestyle/StructureDefinition/physical-activity-lt-lifestyle. CI: https://build.fhir.org/ig/HL7LT/ig-lt-lifestyle/Observation-observation-physical-activity-below-example.html
plan-target-bmi (Target BMI (kg/m²))is related tobmi (BMI (Vital Signs))Target BMI as goal on CarePlan; measured BMI uses vitalsigns BMI profile. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/bmi
grp-achievement (Achievement evaluation)is related toobservation-lt (ObservationLt (LT Base))Achievement evaluation section; aligns with follow-up Observations in this IG (e.g. observation-cvd-followup-*). CVD IG examples bundle with CvdReportLtCvd / CvdCompositionLtCvd as appropriate.
achievement-datetime (Achievement evaluation date and time)is related toobservation-lt (ObservationLt (LT Base))Effective time on follow-up Observations or encounter context. Base profile: https://hl7.lt/fhir/base/StructureDefinition/observation-lt. LT Base IG: https://hl7.lt/fhir/base/ImplementationGuide/lt.hl7.fhir.base
achievement-ldl-mmol (Achieved LDL cholesterol (mmol/l))is related tocholesterol-ldl-lab-ltAchieved LDL: CholesterolLdlLabLt. CI lipidogram: https://build.fhir.org/ig/HL7LT/ig-lt-lab/Observation-observation-lipidogram-example.html
achievement-ldl-target-met (Target LDL achieved (boolean))is related tocare-plan-lt-cvdInterpret against CarePlan LDL goals and latest CholesterolLdlLabLt Observation.
achievement-bp-systolic (Current systolic BP (mmHg))is related toblood-pressure-panel (BloodPressurePanel (Vital Signs))BloodPressurePanel systolic component. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-blood-pressure-example.html
achievement-bp-diastolic (Current diastolic BP (mmHg))is related toblood-pressure-panel (BloodPressurePanel (Vital Signs))BloodPressurePanel diastolic component; same Observation as systolic.
achievement-bp-target-met (Target BP achieved (boolean))is related tocare-plan-lt-cvdInterpret against CarePlan BP goals and BloodPressurePanel Observations.
achievement-comments (Achievement evaluator comments)is related toobservation-lt (ObservationLt (LT Base))Free-text comments; may appear as note on ObservationLt or related resource. StructureDefinition: https://hl7.lt/fhir/base/StructureDefinition/observation-lt
achievement-smoking-quit (Smoking cessation achieved)is related totobacco-use-lt-lifestylemapping.md row 24 — Smoking cessation at achievement; TobaccoUseLtLifestyle vs plan smoking cessation items.
"},"url":"https://hl7.lt/fhir/cvd/ConceptMap/cvd-prevention-plan-questionnaire","version":"0.1.0","name":"CvdPreventionPlanQuestionnaireItemMap","title":"CVD prevention plan questionnaire item to profile mapping","status":"draft","experimental":true,"date":"2025-10-01","publisher":"Lithuanian Medical Library","contact":[{"name":"Lithuanian Medical Library","telecom":[{"system":"url","value":"https://medicinosnk.lt"},{"system":"email","value":"info@medicinosnk.lt"}]}],"description":"Maps ESPBI form 2 Questionnaire linkIds to Lithuanian FHIR profiles and related IGs. Human-readable narrative is in each target.comment. Source: linkId codes; target: profile identifiers (CodeSystem cvd-questionnaire-mapping-target).","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"LT"}]}],"group":[{"source":"https://hl7.lt/fhir/cvd/CodeSystem/cvd-questionnaire-prevention-plan-item|0.1.0","target":"https://hl7.lt/fhir/cvd/CodeSystem/cvd-questionnaire-mapping-target|0.1.0","element":[{"code":"grp-plan-header","target":[{"code":"care-plan-lt-cvd","relationship":"related-to","comment":"Section header for plan metadata, risk group, LDL target, and smoking cessation (CarePlanLtCvd). Example: care-plan-cvd-screening-example. CVD IG: https://hl7.lt/fhir/cvd/ImplementationGuide/lt.hl7.fhir.cvd"}]},{"code":"plan-created-datetime","target":[{"code":"care-plan-lt-cvd","relationship":"related-to","comment":"CarePlan.created / period on CarePlanLtCvd. StructureDefinition: https://hl7.lt/fhir/cvd/StructureDefinition/care-plan-lt-cvd. Example: care-plan-cvd-screening-example."}]},{"code":"plan-risk-group","target":[{"code":"risk-group-ext-lt-cvd","relationship":"related-to","comment":"Risk group on the plan: RiskGroupExtLtCvd on CarePlan and/or persisted RiskGroupObservationLtCvd. Extension: https://hl7.lt/fhir/cvd/StructureDefinition/risk-group-ext-lt-cvd. Example observation: observation-risk-group-high-example."}]},{"code":"plan-target-ldl","target":[{"code":"care-plan-lt-cvd","relationship":"related-to","comment":"Target LDL as CarePlan.goal (e.g. LOINC 18262-6) on CarePlanLtCvd; compare to CholesterolLdlLabLt at follow-up. Lab profile: https://hl7.lt/fhir/lab/StructureDefinition/cholesterol-ldl-lab-lt"}]},{"code":"plan-smoking-cessation","target":[{"code":"care-plan-lt-cvd","relationship":"related-to","comment":"CarePlan.activity for cessation interventions; related behaviour may appear as TobaccoUseLtLifestyle. Lifestyle: https://hl7.lt/fhir/lifestyle/StructureDefinition/tobacco-use-lt-lifestyle"}]},{"code":"grp-plan-lifestyle","target":[{"code":"physical-activity-lt-lifestyle","relationship":"related-to","comment":"Section header for lifestyle and weight (physical activity, target BMI)."}]},{"code":"plan-physical-activity","target":[{"code":"physical-activity-lt-lifestyle","relationship":"related-to","comment":"PhysicalActivityLtLifestyle. StructureDefinition: https://hl7.lt/fhir/lifestyle/StructureDefinition/physical-activity-lt-lifestyle. CI: https://build.fhir.org/ig/HL7LT/ig-lt-lifestyle/Observation-observation-physical-activity-below-example.html"}]},{"code":"plan-target-bmi","target":[{"code":"bmi","relationship":"related-to","comment":"Target BMI as goal on CarePlan; measured BMI uses vitalsigns BMI profile. StructureDefinition: https://hl7.lt/fhir/vitalsigns/StructureDefinition/bmi"}]},{"code":"grp-achievement","target":[{"code":"observation-lt","relationship":"related-to","comment":"Achievement evaluation section; aligns with follow-up Observations in this IG (e.g. observation-cvd-followup-*). CVD IG examples bundle with CvdReportLtCvd / CvdCompositionLtCvd as appropriate."}]},{"code":"achievement-datetime","target":[{"code":"observation-lt","relationship":"related-to","comment":"Effective time on follow-up Observations or encounter context. Base profile: https://hl7.lt/fhir/base/StructureDefinition/observation-lt. LT Base IG: https://hl7.lt/fhir/base/ImplementationGuide/lt.hl7.fhir.base"}]},{"code":"achievement-ldl-mmol","target":[{"code":"cholesterol-ldl-lab-lt","relationship":"related-to","comment":"Achieved LDL: CholesterolLdlLabLt. CI lipidogram: https://build.fhir.org/ig/HL7LT/ig-lt-lab/Observation-observation-lipidogram-example.html"}]},{"code":"achievement-ldl-target-met","target":[{"code":"care-plan-lt-cvd","relationship":"related-to","comment":"Interpret against CarePlan LDL goals and latest CholesterolLdlLabLt Observation."}]},{"code":"achievement-bp-systolic","target":[{"code":"blood-pressure-panel","relationship":"related-to","comment":"BloodPressurePanel systolic component. CI: https://build.fhir.org/ig/HL7LT/ig-lt-vitalsigns/Observation-observation-blood-pressure-example.html"}]},{"code":"achievement-bp-diastolic","target":[{"code":"blood-pressure-panel","relationship":"related-to","comment":"BloodPressurePanel diastolic component; same Observation as systolic."}]},{"code":"achievement-bp-target-met","target":[{"code":"care-plan-lt-cvd","relationship":"related-to","comment":"Interpret against CarePlan BP goals and BloodPressurePanel Observations."}]},{"code":"achievement-comments","target":[{"code":"observation-lt","relationship":"related-to","comment":"Free-text comments; may appear as note on ObservationLt or related resource. StructureDefinition: https://hl7.lt/fhir/base/StructureDefinition/observation-lt"}]},{"code":"achievement-smoking-quit","target":[{"code":"tobacco-use-lt-lifestyle","relationship":"related-to","comment":"mapping.md row 24 — Smoking cessation at achievement; TobaccoUseLtLifestyle vs plan smoking cessation items."}]}]}]}}]}